ID

12953

Beschrijving

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01467323

Link

https://clinicaltrials.gov/show/NCT01467323

Trefwoorden

  1. 07-01-16 07-01-16 -
Houder van rechten

CC BY-NC 3.0

Geüploaded op

7 januari 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT01467323

Eligibility Diabetes NCT01467323

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01467323
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months
Beschrijving

insulin requiring type 1 or type 2 diabetes

Datatype

boolean

Alias
UMLS CUI [1]
C0011849
current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months
Beschrijving

insulin

Datatype

boolean

Alias
UMLS CUI [1]
C0021641
body mass index (bmi) below or equal to 35.0 kg/m^2
Beschrijving

body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
hba1c below or equal to 11.0%
Beschrijving

hba1c

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
total daily insulin dose at least 1.4 iu/kg
Beschrijving

total daily insulin dose at least 1.4 iu/kg

Datatype

boolean

Alias
UMLS CUI [1]
C0021641
treatment with oral hypoglycaemic agents within the month prior to inclusion
Beschrijving

oral hypoglycaemic agents

Datatype

boolean

Alias
UMLS CUI [1]
C0359086
recurrent severe hypoglycaemia (as judged by the investigator)
Beschrijving

hypoglycemia

Datatype

boolean

Alias
UMLS CUI [1]
C0020615
active proliferative retinopathy
Beschrijving

proliferative retinopathy

Datatype

boolean

Alias
UMLS CUI [1]
C0339467
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
Beschrijving

impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
history of pancreatitis
Beschrijving

pancreatitis

Datatype

boolean

Alias
UMLS CUI [1]
C0030305

Similar models

Eligibility Diabetes NCT01467323

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01467323
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
insulin requiring type 1 or type 2 diabetes
Item
subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months
boolean
C0011849 (UMLS CUI [1])
insulin
Item
current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months
boolean
C0021641 (UMLS CUI [1])
body mass index
Item
body mass index (bmi) below or equal to 35.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
hba1c
Item
hba1c below or equal to 11.0%
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
total daily insulin dose at least 1.4 iu/kg
Item
total daily insulin dose at least 1.4 iu/kg
boolean
C0021641 (UMLS CUI [1])
oral hypoglycaemic agents
Item
treatment with oral hypoglycaemic agents within the month prior to inclusion
boolean
C0359086 (UMLS CUI [1])
hypoglycemia
Item
recurrent severe hypoglycaemia (as judged by the investigator)
boolean
C0020615 (UMLS CUI [1])
proliferative retinopathy
Item
active proliferative retinopathy
boolean
C0339467 (UMLS CUI [1])
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
Item
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
boolean
C0201976 (UMLS CUI [1])
pancreatitis
Item
history of pancreatitis
boolean
C0030305 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial